Skip to main content
Travis Hollmann, MD, Pathology, New York, NY, Memorial Sloan Kettering Cancer Center

TravisJasonHollmannMD

Pathology New York, NY

Dermatopathology, Anatomic Pathology, Clinical Pathology

Assistant Professor

Dr. Hollmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hollmann's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Dermatopathology, 2008 - 2009
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2005 - 2008
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2012 - 2026
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • CA State Medical License
    CA State Medical License 2023 - 2025
  • RI State Medical License
    RI State Medical License 2023 - 2024
  • MA State Medical License
    MA State Medical License 2009 - 2012
  • PA State Medical License
    PA State Medical License 2012 - 2012
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Dermatopathology

Publications & Presentations

PubMed

Journal Articles

  • Massively Parallel Sequencing Analysis of Benign Melanocytic Nevi  
    Allan C Halpern, Travis J Hollmann, Klaus J Busam, Histopathology
  • Microenvironment-Derived Factors Driving Metastatic Plasticity in Melanoma  
    Liang Lu, Travis Hollmann, Nature

Abstracts/Posters

  • Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma
    Travis Hollmann, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report
    Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case ReportMarch 12th, 2021
  • For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size
    For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor SizeMarch 26th, 2019

Hospital Affiliations